Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: Design, synthesis and biological screening
作者:Sharad Kumar Suthar、Varun Jaiswal、Sandeep Lohan、Sumit Bansal、Anil Chaudhary、Amit Tiwari、Angel Treasa Alex、Alex Joesph
DOI:10.1016/j.ejmech.2013.03.011
日期:2013.5
regulate various genes involved in cancer and inflammation. Accordingly, drugs suppressing or inhibiting NF-κB may possess both anti-inflammatory and anticancer properties. A library of quinolone substituted thiazolidin-4-ones was docked into the active site of NF-κB and the top-ranked 31 compounds were synthesized and evaluated for anti-inflammatory and anticancer activity. The best-ranked compound
据报道,核因子-κB(NF-κB)调节与癌症和炎症有关的各种基因。因此,抑制或抑制NF-κB的药物可同时具有抗炎和抗癌特性。将一个喹诺酮取代的噻唑烷酮-4-酮文库对接至NF-κB的活性位点,并合成排名靠前的31种化合物,并评估其抗炎和抗癌活性。在角叉菜胶诱发的爪水肿模型中,排名最高的化合物6b显示出最高的抗炎活性。体外抗癌研究表明1a和16a是对抗BT-549,HeLa,COLO-205和ACHN人类癌细胞系最有效的化合物。化合物1a和16a表现出依赖于NF-κB的抗癌特性和凋亡介导的细胞死亡。体内Ehrlich腹水癌研究进一步证实了1a和16a的抗肿瘤活性。